Seeking Alpha

The FDA lifts a clinical hold on Lpath's (LPTN.OB) iSONEP, an antibody the firm is developing to...

The FDA lifts a clinical hold on Lpath's (LPTN.OB) iSONEP, an antibody the firm is developing to treat wet AMD and possibly other eye disorders. The FDA placed the hold in January after finding that a contractor was not complying with its regulations, but Lpath has since replaced the supplier. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs